No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
HUMA250117C1500
- 3.30
- +0.60+22.22%
15min DelayClose Dec 20 16:00 ET
3.30High3.30Low
3.30Open2.70Pre Close3 Volume3 Open Interest1.50Strike Price990.00Turnover190.78%IV3.45%PremiumJan 17, 2025Expiry Date3.14Intrinsic Value100Multiplier25DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type0.9938Delta0.0075Gamma1.47Leverage Ratio-0.0009Theta0.0010Rho1.46Eff Leverage0.0002Vega
Intraday
- 5D
- Daily
News
Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Ligand Pharma (LGND)
Express News | Humacyte Inc : Benchmark Raises Target Price to $17 From $15
12 Health Care Stocks Moving In Friday's Pre-Market Session
TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10
BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright Maintains Humacyte(HUMA.US) With Buy Rating, Raises Target Price to $15